According to the latest report by IMARC Group, titled “Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2025-2033”, the global intravenous solutions market size reached USD 15.6 Billion in 2024. Intravenous (IV) solutions, also known as intravenous fluids, are administered to a patient to provide salt, sugar and water directly into their venous circulation. It is required when an individual is ill, going through an operation or is not in the condition to eat or drink. IV solutions and electrolytes are mainly used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and fluids have become an integral part of modern therapy.
Global Intravenous Solutions Market Trends:
Over the past few years, the prevalence of hectic work schedules and unhealthy lifestyles has increased across the globe. The consequent decline in physical activity and proper nutrition has led to a rise in the incidences of chronic diseases, which in turn has boosted the demand for intravenous solutions. Besides, there has been significant growth in the production of IV fluids, particularly in developed countries. For instance, it was reported that due to the shortage of IV saline, the US Food and Drug Administration (FDA) and other market players have been making efforts to mitigate the crisis. In line with this, the US-based marketing and technology company, Merge, partnered with the innovative medical products and services provider, B. Braun Medical, to introduce the ‘Solutions for Life’ omnichannel campaign in May 2019. This initiative is aimed to ensure a consistent supply of IV solutions, approved by the US FDA, across the country. Looking forward, the market value is projected to reach USD 23.3 Billion by 2033, expanding at a CAGR of 4.53% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Type, Nutrients, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered | Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal